Clinical Trial Update: Extension Study of Cinacalcet for Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Patients With Chronic Kidney Disease on Dialysis [Phase 3]

View source ↗

Summary

Extension study of cinacalcet for secondary hyperparathyroidism in pediatric CKD patients on dialysis completed; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperparathyroidism

Drugs mentioned

• cinacalcet (cinacalcet hydrochloride)

Snippet

Sponsor: Amgen | Conditions: Secondary Hyperparathyroidism, Chronic Kidney Disease | Phase 3 | Status: COMPLETED | Results posted: 2018-05-18